QIAGEN N.V.: QIAGEN showcases latest technologies to advance cancer research at AACR Annual Meeting 2023
Venlo, the Netherlands, April 14, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAseq Targeted cfDNA Ultra Panels that will enable researchers
United States Thomas Schweins University Of Pisa Life Sciences Business Area American Association For Cancer Research Exchange Commission
Source: finanznachrichten.de